iseganan

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2016
02420022016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
1 Grant I, Heaton RK, McSweeney AJ, et al. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch… (More)
Is this relevant?
2006
2006
RATIONALE Iseganan, an antimicrobial peptide, is active against aerobic and anaerobic gram-positive and gram-negative bacteria as… (More)
Is this relevant?
2006
2006
Yeast-like fungi are the most common cause of fungal infections in humans. Actually, in the age of opportunistic infections and… (More)
  • table I
  • table II
  • table III
Is this relevant?
2004
2004
PURPOSE Oral mucositis (OM) causes significant morbidity during the course of radiotherapy (RT) treatment of head-and-neck cancer… (More)
Is this relevant?
2004
2004
The invasion and colonization of oral cavity mucosal tissues by microflora may contribute to the pathophysiology of ulcerative… (More)
Is this relevant?
2003
2003
Microfloral invasion and colonization of oral cavity mucosal tissues contribute to the pathophysiology of ulcerative oral… (More)
Is this relevant?
2003
2003
BACKGROUND No single oral mucositis (OM) assessment scale is universally accepted; the most commonly used scales are deficient… (More)
Is this relevant?
Review
2002
Review
2002
Iseganan HCl is an antimicrobial peptide under development for the prevention of oral mucositis, a severe consequence of some… (More)
Is this relevant?
Review
2002
Review
2002
Iseganan (IB-367) is a protegrin under development by IntraBiotics, as part of a larger protegrin program, for the potential… (More)
Is this relevant?
Review
2002
Review
2002
Innate host defence, involving both cellular and humoral mediators, is a prominent function of the human airways. Cellular… (More)
Is this relevant?